Non-Tuberculous Mycobacteria (NTM) infections, particularly those caused by Mycobacterium abscessus, are of increasing ...

There is no highly effective vaccine against tuberculosis (TB), which remains an infection of global concern. Charles ...

The country accounted for about 4% of the Asia-Pacific market in 2024. Japan’s mycobacterium tuberculosis (TB) tests market ...

Consultant respiratory physician at University Hospital Southampton NHS Foundation Trust, Dr Ben Marshall, will embark on the ...

The research team demonstrated that innate immune cells called Natural Killer (NK) cells that express CD8a on the cell surface (a receptor usually associated with T cells) are reactive to human ...

A doctor who lives in Winchester is gearing up to embark on a 950-mile cycle ride across France. Dr Ben Marshall, a consultant respiratory physician at University Hospital Southampton NHS Foundation ...

Nontuberculous mycobacteria (NTM ... British Thoracic Society Guideline for the management of non-tuberculosis mycobacterial pulmonary disease (NTM-PD). BMJ Open Resp Res; 4: e000242.

Tuberculosis, TB, is caused by the germ Mycobacterium tuberculosis and primarily affects ... Though anyone can contract TB, the disease disproportionately affects non-U.S.-born people, according to ...

Mycobacterium tuberculosis causes long-term infections characterised by slow or non-replicating growth states and controlled gene expression. This study finds these bacteria as the first example of an ...

DC-specific ICAM3-grabbing non-integrin (DC-SIGN) interacts with mannose-carrying pathogens including Mycobacterium tuberculosis, HIV-1, measles virus and Candida albicans to activate the serine ...